Variant report
Variant | esv2577640 |
---|---|
Chromosome Location | chr10:92052015-92053408 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:92051318..92054074-chr10:92099394..92101764,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541668902 | chr10:92052044-92052045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556766829 | chr10:92052066-92052067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116233871 | chr10:92052072-92052073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7919251 | chr10:92052096-92052097 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs7919262 | chr10:92052117-92052118 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs181249193 | chr10:92052165-92052166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147621834 | chr10:92052170-92052171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370217093 | chr10:92052172-92052173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149081078 | chr10:92052259-92052260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529040681 | chr10:92052278-92052279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142878353 | chr10:92052351-92052352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186273622 | chr10:92052358-92052359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531619316 | chr10:92052368-92052369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7905038 | chr10:92052377-92052378 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs190599144 | chr10:92052391-92052392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151056181 | chr10:92052406-92052407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368849548 | chr10:92052424-92052425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111300460 | chr10:92052429-92052430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140938641 | chr10:92052436-92052437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536810623 | chr10:92052509-92052510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556592526 | chr10:92052511-92052512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144947969 | chr10:92052528-92052529 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138809305 | chr10:92052529-92052530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184088373 | chr10:92052554-92052555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7922885 | chr10:92052568-92052569 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs201222964 | chr10:92052609-92052610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539957820 | chr10:92052622-92052623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140746235 | chr10:92052628-92052629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573770519 | chr10:92052672-92052673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377560104 | chr10:92052684-92052685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187603619 | chr10:92052703-92052704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570240808 | chr10:92052780-92052781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562668827 | chr10:92052877-92052878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531486442 | chr10:92052925-92052926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545038932 | chr10:92052934-92052935 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536109261 | chr10:92052979-92052980 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190580522 | chr10:92052985-92052986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548462149 | chr10:92053003-92053004 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564934248 | chr10:92053033-92053034 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74148529 | chr10:92053043-92053044 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs1887183 | chr10:92053061-92053062 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs567713802 | chr10:92053068-92053069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376951835 | chr10:92053089-92053090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117482193 | chr10:92053108-92053109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs80261504 | chr10:92053110-92053111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570406064 | chr10:92053124-92053125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116602647 | chr10:92053125-92053126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558268684 | chr10:92053126-92053127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111820861 | chr10:92053136-92053137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571274692 | chr10:92053145-92053146 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neurocytoma | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Lung cancer | 21911935 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:92048200-92053600 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr10:92048600-92053400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr10:92048800-92054200 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr10:92049000-92054400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
5 | chr10:92049000-92055000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr10:92049400-92053400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr10:92049400-92053600 | Weak transcription | NHEK | skin |
8 | chr10:92049800-92052600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr10:92050000-92054000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr10:92050600-92053400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr10:92050600-92054000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr10:92050800-92053600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr10:92051400-92052400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr10:92052400-92054600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr10:92052600-92053600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
16 | chr10:92052800-92053000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr10:92053000-92055000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
18 | chr10:92053400-92053600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr10:92053400-92053800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr10:92053400-92054000 | Enhancers | HUES6 Cell Line | embryonic stem cell |